Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Discover the latest content that has just been published on Research Tree
Ametek continued to deliver excellent results with strong growth in the fourth quarter as well. The company delivered an all-around beat in this quarter and has seen a positive impact in the organic growth initiatives. In this quarter, the sales were up 8% over the same period in 2021. On the other hand, the organic sales growth was 9%. The company also had a backlog of $3.22 billion. The company is also working on its acquisition strategies as well. The management expects to remain active in 20
Companies: AMETEK (AME:NYSE)AMETEK, Inc. (AME:NYS)
Baptista Research
Ametek’s stock price has surged as the company delivered excellent results with strong sales growth as well as solid operational execution, thus leading to high earnings, both of which were well above market expectations. Operationally, the company's businesses are performing quite well and offsetting inflation successfully with price increases, thus resulting in an impressive margin expansion. Ametek also sees continued broad-based and strong demand across its diversified niche markets that lea
Ametek was able to surpass Wall Street expectations on all fronts in the previous quarter as a result of stronger-than-anticipated organic sales growth and impressive margin improvement. The demand in the company’s many specialty markets is very strong and broad-based, which has resulted in exceptional organic order growth and a robust backlog of $3.1 billion. Their EIG businesses continue to have very significant organic growth, with Ultra Precision Technologies and P&AI divisions showing parti
Companies: AMETEK, Inc. (AME:NYS)AMETEK, Inc. (0HF7:LON)
Ametek had a strong first quarter, with strong sales growth and excellent operating performance, resulting in robust core margin expansion and earnings that exceeded the company’s expectations. The company’s $1.46 billion worth of revenues were up 20% from the same period in 2021 driven by a 14% jump in organic sales. Its core Electronic Instruments Group (EIG) business which accounts for around two-thirds of the business grew by 31% whereas its Electromechanical Group (EMG) segment was relative
The year 2021 was particularly good for Ametek as the company delivered a strong operating performance, earnings above expectations, and better than expected sales growth. Strong demand is seen all over Ametek's diverse set of end markets, leading to a record backlog and robust order growth. However, the logistics and global supply chain networks along with inflation remain a challenge for the management. Ametek managed to carry out a high level of capital deployment that led to acquiring five s
Ametek had a very strong 2021 with earnings above expectations, strong operating performance, and better than expected sales growth. Strong demand is seen all over the company's diverse set of end markets, leading to a record backlog and robust order growth. However, the logistics and global supply chain networks along with inflation remain a challenge for the management. Ametek managed to carry out a high level of capital deployment that led to acquiring five strategic businesses. They are also
Ametek had another exceptional quarter, with better than expected sales growth, strong operating performance, and earnings that exceeded their expectations. Demand remained strong across its diverse end markets, resulting in strong order growth and a record backlog. While the global supply chain and logistics networks remain challenging, the management is doing an excellent job of navigating these issues and delivering results that exceed the market expectations. The company saw a staggering 28%
Ametek delivered exceptional results in the second quarter with compelling sales growth and excellent operating performance, leading to a high quality of earnings that exceeded the company's expectations. The company ended the quarter with a record backlog driven by robust and broad-based orders growth, providing strong visibility across their mid and long-cycle business profile. It is worth highlighting that their quarterly orders grew by $1.91 billion, a sharp increase of 92% compared to the p
Research Tree provides access to ongoing research coverage, media content and regulatory news on AMETEK, Inc.. We currently have 15 research reports from 3 professional analysts.
Re-issued to correct for typographical errors.Invinity’s major equity fundraising is targeting a minimum of £56m with £25m already committed by the UK Infrastructure Bank (UKIB). A second strategic investment of £3m has been committed by Korean Investment Partners. The raise will see Invinity to net cash generation, with over £30m of the raise supporting the company’s scale up ahead of this year’s launch of the next generation Mistral flow battery. The raise will boost the balance sheet, reduci
Companies: Invinity Energy Systems PLC
Longspur Clean Energy
Invinity Energy Systems (IES LN) develops Vanadium Flow Batteries (VFBs) for utility-scale grid storage. The Group’s next-generation Mistral VFB technology, jointly developed with Gamesa Electric, launches in H2 2024 to provide grid-scale longer-duration energy storage (LDES) as renewable generation increases globally. To capture this opportunity, the Group has today announced that it has raised £56.0m through a placing at 23p per share. It is now undertaking an Open Offer to raise up to £6.6m a
VSA Capital
Market sentiment turned more cautious in the month of April, particularly regarding interest rates, with economic data producing mixed results. Despite housing transactions and net mortgage approvals continuing an upward trend, with the latter at an 18-month high and +20.1% YoY and +1.4% MoM to 61.3k (seasonally adjusted), Nationwide’s House Price Index dropped 0.4% MoM (seasonally adjusted) in April, below the +0.2% expected. This comes as mortgage lenders nudge rates up to factor in the potent
Companies: TPT EPWN VANL NXR LIKE
Zeus Capital
The focus of Hardman & Co Research is on the nine quoted Infrastructure Investment Companies (IICs) and on the 22 Renewable Energy Infrastructure Funds (REIFs): the stocks analysed are all members of the Association of Investment Companies (AIC). We are updating our publication of January 2023, assessing both the lacklustre share price performances during 2023 and the key issues, including interest rates, inflation and power prices. As a 31-strong group, its combined market capitalisation is no
Companies: AEIT ROOF DGI9 INPP GSF SEIT USFP HICL ORIT BSIF TRIG NESF SEQI HEIT GRP GCP FSFL 3IN AERI PINT RNEW BBGI GSEO DORE TENT GRID CORD HGEN AEET
Hardman & Co
SDI has indicated that a slowdown in the life science / biotech market, and some resultant destocking, is likely to impact its expected FY24 revenue, leading the group to moderate current year guidance for both revenue and adjusted EBITDA. SDI notes that FY24 represents a short-term phenomenon, due to the over-ordering of the past three years caused by inflated Covid demand. However, we remain confident for the long term, given the strength of SDI’s ‘buy and build’ business model, with a number
Companies: SDI Group plc
Progressive Equity Research
Companies: ALB CS ALB GLEN MP
SP Angel
Invinity’s major equity fundraising is targeting a minimum of £50m with half already committed by the UK Infrastructure Bank (UKIB). A second strategic investment of £3m has been committed by Korean Investment Partners. The raise will see Invinity to net cash generation, with £30m of the raise supporting the company’s scale up ahead of this year’s launch of the next generation Mistral flow battery. The raise will boost the balance sheet, reducing counterparty risk and unlocking sales and bigger
The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. For the second year running, apart from global economic influences affecting world markets, performance in 2023 was dented by the capital-intensive nature of the sector. The HHI fell 3.7%, to 483.8, underperforming the main London markets – FTSE 100 (+3.8%) and FTSE All-Share (3.8%) but outperforming the FTSE AIM All-Share Index (
Companies: TXG NDVA TSVT BCOW Z29 TXG NCYT GNS SUN AMS OMG APH EKF EAH IMM AGL DEMG AGY TSTL IPO GDR ETX TRX HVO CTEC AVO OXB DEST VLG IXI VAL INDV AGR AVCT BAI 123F IMCR BCOW
XP Power closed FY23 with higher-than-expected revenue, benefiting from the delay to relocation of its California facility, which pulled shipments worth c £5m into Q423 and pushed c £12m capex into Q124. Q423 order intake was higher than we forecast, with upside from semiconductor equipment customers partially offset by weaker demand from healthcare and industrial customers. Timing issues and currency resulted in lower-than-expected gearing at end-FY23, although it is expected to rise in H124 be
Companies: XP Power Ltd.
Edison
Companies: AVZ AAU ORR JAY CUSN SVML GMET PLL
Zonal pricing is now under consideration for implementation in the GB power market. While this is very much not a given, this note summarises the key reports on its potential impacts. We find that while there is an overall reduction in revenues across generation, this may be less than originally predicted and new regional price differences and timing differences may favour storage in Scotland and delay new gas plant construction nationally. We think this later second order impact improves the en
Companies: DRX NESF IES SAE
Companies: Iofina plc
Canaccord Genuity
Plant Health Care announced it has signed a distribution agreement with AMVAC, an American Vanguard Company, to support commercialisation of novel fertiliser products incorporating Plant Health Care's Harpinαβ in China starting in 2024. The novel product combines Harpinαβ technology with an AMVAC fertiliser and is expected to help growers improve crop quality and yield as part of an integrated and environmentally responsible crop production programme. AMVAC continues to evaluate Plant Health Car
Companies: Plant Health Care PLC
Cavendish
Companies: CNC RNO MAI IUG CUSN POLB
The FY24 year-end update is very upbeat signalling trading being materially ahead of expectations, with a better-than-expected profit out turn and stronger cash generation. It continues to strengthen margins through efficiencies and investment in modern equipment. The order book remains close to record levels providing a robust view of future forecasts. In FY24E we upgrade EPS by 11% and in FY25E a significant upgrade of 27.6%. It looks capable of declaring a dividend in FY25 as well as manageme
Companies: Renold plc
Share: